Bioengineered surfaces to improve the blood compatibility of biomaterials through direct thrombin inactivation
- 1 November 2012
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 8 (11) , 4101-4110
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Nonthrombogenic Approaches to Cardiovascular BioengineeringAnnual Review of Biomedical Engineering, 2011
- Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactionsActa Biomaterialia, 2011
- Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrateActa Biomaterialia, 2010
- The effect of immobilization of thrombin inhibitors onto self-assembled monolayers on the adsorption and activity of thrombinBiomaterials, 2010
- Protein adsorption and clotting time of pHEMA hydrogels modified with C18 ligands to adsorb albumin selectively and reversiblyBiomaterials, 2009
- Isolation, Cloning and Structural Characterisation of Boophilin, a Multifunctional Kunitz-Type Proteinase Inhibitor from the Cattle TickPLOS ONE, 2008
- Molecularly designed surfaces for blood deheparinization using an immobilized heparin‐binding peptideJournal of Biomedical Materials Research Part A, 2008
- Complement and coagulation: strangers or partners in crime?Trends in Immunology, 2007
- Factors that Determine the Protein Resistance of Oligoether Self-Assembled Monolayers − Internal Hydrophilicity, Terminal Hydrophilicity, and Lateral Packing DensityJournal of the American Chemical Society, 2003
- Oriented immobilization of proteinsMicrochimica Acta, 1998